However, assessment of BCR-ABL1 as MRD marker in CML showed us the technical difficulties of standard curves and in achieving an inter-laboratory comparability to ensure consistent analyses [22]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.